Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 5, 2008 - Issue 12
Submit an article Journal homepage
93
Views
10
CrossRef citations to date
0
Altmetric
Review

Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection

Zhi-Yang Chang PhD Student National Defense Medical Center, Graduate Institute of Life Sciences,
,
Chiao-Hsi Chiang Professor National Defense Medical Center, School of Pharmacy, Neihu, Taipei 114, Taiwan
,
Da-Wen Lu Associate Professor Tri-Service General Hospital, Department of Ophthalmology
&
Ming-Kung Yeh Professor Tri-Service General Hospital, National Defense Medical Center, Department of Clinical Pharmacy, No 325, Section 2, Chen-Kung Road, Neihu, Taipei 114, Taiwan +886 2 87926947; +886 2 87926947; [email protected]
Pages 1313-1321 | Published online: 01 Dec 2008

Bibliography

  • Kendall RG. Erythropoietin. Clin Lab Haematol 2001;23:71-80
  • Dube S, Fisher JW, Powell JS. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem 1988;263:17516-21
  • Elliott S, Lorenzini T, Chang D, et al. Mapping of the active site of recombinant human erythropoietin. Blood 1997;89:493-502
  • Storring PL, Tiplady RJ, Gaines Das RE, et al. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. Br J Haematol 1998;100:79-89
  • Jelkmann W. Recombinant EPO production – points the nephrologist should know. Nephrol Dial Transplant 2007;22:2749-53
  • Elliott S, Lorenzini T, Asher S, et al. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 2003;21:414-21
  • Siren AL, Ehrenreich H. Erythropoietin – a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 2001;251:179-84
  • Tsai JC, Song BJ, Wu L, et al. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. J Glaucoma 2007;16:567-71
  • Yatsiv I, Grigoriadis N, Simeonidou C, et al. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury FASEB J 2005;19:1701-3
  • Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 2007;48:1212-8
  • Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353:782-92
  • van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000;17:1159-67
  • Michael M, Hans K, Gerhard W, et al. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide) protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 1997;43:29-36
  • Bittner B, Morlock M, Koll H, et al. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm 1998;45:295-305
  • Morlock M, Kissel T, Li YX, et al. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in vitro release properties. J Control Rel 1998;56:105-15
  • Pistel KF, Bittner B, Koll H, et al. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. J Control Release 1999;59:309-25
  • Myung JK, Sun JK, Oh RK. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid. US7276251B2; 2007
  • Casadevall N, Rossert J. Importance of biologic follow-ons: experience with EPO. Best Pract Res Clin Haematol 2005;18:381-7
  • Chiang CH, Yeh MK. Contribution of poly(amino acids) to advances in pharmaceutical biotechnology. Curr Pharm Biotechnol 2003;4:323-30
  • Yeh MK, Chen JL, Chiang CH, et al. The preparation of sustained release erythropoietin microparticle. J Microencapsul 2007;24:82-93
  • Stephen EZ, Paul AB, Howard B, et al. Composition for sustained release of non-aggregated erythropoietin. US5716644; 1998
  • Herberger J, Murphy K, Munyakazi L, et al. Carbon dioxide extraction of residual solvents in poly(lactide-co-glycolide) microparticles. J Control Release 2003;90:181-95
  • Nguyen XC, Herberger JD, Burke PA. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm Res 2004;21:507-14
  • Burke PA, Klumb LA, Herberger JD, et al. Poly(lactide-co-glycolide) microsphere formulations of darbepoetin alfa: spray drying is an alternative to encapsulation by spray-freeze drying. Pharm Res 2004;21:500-6
  • Moriya H, Maitani Y, Shimoda N, et al. Pharmacokinetic and pharmacological profiles of free and liposomal recombinant human erythropoietin after intravenous and subcutaneous administrations in rats. Pharm Res 1997;14:1621-8
  • Ulrich H, Trujillo CA, Nery AA, Alves JM, Majumder P, Resende RR, et al. DNA and RNA aptamers: from tools for basic research towards therapeutic applications. Comb Chem High Throughput Screen 2006;9:619-32
  • Lukyanov AN, Elbayoumi TA, Chakilam AR, et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Control Rel 2004;100:135-44
  • Farokhzad OC, Jon S, Khademhosseini A, et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 2004;64:7668-72
  • Healy JM, Lewis SD, Kurz M, et al. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm Res 2004;21:2234-46
  • Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc Natl Acad Sci USA 2006;103:6315-20
  • Shinjo K, Takeshita A, Higuchi M, et al. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay. Br J Haematol 1997;96:551-8
  • Pang IH, Zeng H, Fleenor DL, et al. Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci 2007;8:11
  • Csete M, Rodriguez L, Wilcox M, et al. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci Lett 2004;359:124-6
  • Macdougall IC. CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemia. Curr Hematol Rep 2005;4:436-40
  • Josef B, Bernd H, Hans PJ. Erythropoietin conjugates. US6340742B1; 2002
  • Pascal SB. Erythropoietin conjugates. US6583272B1; 2003
  • Jolling K, Perez Ruixo JJ, Hemeryck A, et al. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin. Eur J Pharm Sci 2005;24:465-75
  • Macdougall IC, Robson R, Opatrna S, et al. Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease. Clin J Am Soc Nephrol 2006;1:1211-5
  • Qi XR, Maitani Y, Nagai T, et al. Comparative pharmacokinetics and antitumor efficacy of doxorubicin encapsulated in soybean-derived sterols and poly(ethylene glycol) liposomes in mice. Int J Pharm 1997;146:31-9
  • Sytkowski AJ, Lunn ED, Davis KL, et al. Human erythropoietin dimers with markedly enhanced in vivo activity. Proc Natl Acad Sci USA 1998;95:1184-8
  • Sytkowski AJ, Lunn ED, Risinger MA, et al. An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties. J Biol Chem 1999;274:24773-8
  • Dalle B, Henri A, Rouyer-Fessard P, et al. Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo Blood 2001;97:3776-82
  • Battaglia A, Fattorossi A, Pierelli L, et al. The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis. Exp Hematol 2000;28:490-8
  • Lee DE, Oh MS, Chung BS, et al. Fusion protein having enhanced in vivo activity of erythropoietin. US7098318; 2006
  • Bitonti AJ, Dumont JA, Low SC, et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci USA 2004;101:9763-8
  • Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001;84(Suppl 1):3-10
  • Macdougall IC, Gray SJ, Elston O, et al. Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 1999;10:2392-5
  • Sugasawa K, Deguchi J, Okami T, et al. Immunocytochemical analyses of distributions of Na, K-ATPase and GLUT1, insulin and transferrin receptors in the developing retinal pigment epithelial cells. Cell Struct Funct 1994;19:21-8
  • Dehouck B, Fenart L, Dehouck MP, et al. A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J Cell Biol 1997;138:877-89
  • Coloma MJ, Lee HJ, Kurihara A, et al. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 2000;17:266-74
  • Boado RJ, Zhang Y, Xia CF, et al. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood–brain barrier and abeta fibril disaggregation. Bioconjug Chem 2007;18:447-55
  • Pardridge WM, Kang YS, Buciak JL. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood–brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 1994;11:738-46
  • Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 2000;97:7567-72
  • Spandou E, Papadopoulou Z, Soubasi V, et al. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 2005;1045:22-30
  • Wang L, Zhang Z, Wang Y, et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732-7
  • Viviani B, Bartesaghi S, Corsini E, et al. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem 2005;93:412-21
  • Ehrenreich H, Timner W, Siren AL. A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfus Apher Sci 2004;31:39-44
  • Yasuda Y, Fujita Y, Masuda S, et al. Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 2002;23:1797-805
  • Yasuda Y, Fujita Y, Matsuo T, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003;24:1021-9
  • Pardridge WM, Wu D, Sakane T. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm Res 1998;15:576-82
  • Chekhonin VP, Zhirkov YA, Gurina OI, et al. PEGylated immunoliposomes directed against brain astrocytes. Drug Deliv 2005;12:1-6
  • Gaillard PJ, Voorwinden LH, Nielsen JL, et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 2001;12:215-22
  • Shoge K, Mishima HK, Mukai S, et al. Rat retinal ganglion cells culture enriched with the magnetic cell sorter. Neurosci Lett 1999;259:111-4
  • Morishita E, Masuda S, Nagao M, et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997;76:105-16
  • Toimela T, Maenpaa H, Mannerstrom M, et al. Development of an in vitro blood–brain barrier model – cytotoxicity of mercury and aluminum. Toxicol Appl Pharmacol 2004;195:73-82
  • Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002;99:10659-64
  • Grunfeld JF, Barhum Y, Blondheim N, et al. Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model. Exp Neurol 2007;204:260-3
  • Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97:10526-31
  • Zhang J, Li Y, Cui Y, et al. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 2005;1034:34-9
  • Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001;98:4044-9
  • Weishaupt JH, Rohde G, Polking E, et al. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45:1514-22
  • Genc S, Kuralay F, Genc K, et al. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 2001;298:139-41
  • Xue YQ, Zhao LR, Guo WP, et al. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 2007;146:1245-58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.